Assessment of CYP2D6 and CY2C19 activity in vivo in humans:: A cocktail study with dextromethorphan and chloroguanide alone and in combination

被引:24
作者
Tennezé, L
Verstuyft, C
Becquemont, L
Poirier, JM
Wilkinson, GR
Funck-Brentano, C
机构
[1] St Antoine Univ Hosp, Clin Invest Ctr, Paris, France
[2] St Antoine Univ Hosp, Dept Pharmacol, Paris, France
[3] Ambroise Pare Univ Hosp, Lab Toxicol & Clin Pharmacokinet, Boulogne, France
[4] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA
关键词
D O I
10.1016/S0009-9236(99)90066-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Dextromethorphan and chloroguanide (INN, proguanil) are used as prototypic phenotyping substrates of polymorphically expressed CYP2D6 and CYP2C19 in humans. We determined whether the dextromethorphan/dextrorphan and chloroguanide/cycloguanil metabolic ratios, obtained after administration of the parent drugs either alone or in combination, are equivalent. Methods: Thirty-six healthy male volunteers received single oral doses of 80 mg dextromethorphan and 200 mg chloroguanide during a three-period, randomized crossover study. Plasma and urine were collected to calculate metabolic ratios and analyze the disposition kinetics of the probe drugs, Results: ALL subjects were extensive metabolizers for both CYP2D6 and CYP2C19, Chloroguanide kinetics and urinary metabolic ratio were not altered after dextromethorphan administration. Dextromethorphan urinary metabolic ratio increased from -2.52 +/- 0.67 to -2.03 +/- 0.58 (P < .001) in the presence of chloroguanide, This was caused by an increase of dextromethorphan without a significant change of dextrorphan in both urine and plasma, Inhibition of CYP3A-dependent biotransformation of dextromethorphan to methoxymorphinan did not appear to be responsible for this change because the log(dextromethorphan/methoxymorphinan) urinary ratio, an index of CYP3A activity, did not significantly change during chloroguanide coadministration, The chloroguanide and dextromethorphan metabolic ratio determined from urine collection correlated with the corresponding metabolic ratio determined from plasma obtained 3 hours after oral administration, Conclusion: When CYP2D6 and CYP2C19 activity are assessed, dextromethorphan and chloroguanide cannot be associated in a cocktail because chloroguanide increases the dextromethorphan metabolic ratio. CYP2D6 and CPP2C19 activity can be determined from a blood sample drawn 3 hours after oral administration of dextromethorphan and chloroguanide, respectively.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 22 条
  • [1] Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population
    Basci, NE
    Bozkurt, A
    Kortunay, S
    Isimer, A
    Sayal, A
    Kayaalp, SO
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (06) : 771 - 773
  • [2] BROCKMOLLER J, 1995, PHARMACOGENETICS, V5, P80
  • [3] SIMULTANEOUS ADMINISTRATION OF MULTIPLE MODEL SUBSTRATES TO ASSESS HEPATIC DRUG CLEARANCE
    CROM, WR
    WEBSTER, SL
    BOBO, L
    TERESI, ME
    RELLING, MV
    EVANS, WE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (06) : 645 - 650
  • [4] Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity
    Ducharme, J
    Abdullah, S
    Wainer, IW
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 678 (01): : 113 - 128
  • [5] DETERMINATION OF DEXTROMETHORPHAN AND METABOLITES IN HUMAN-PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    EAST, T
    DYE, D
    [J]. JOURNAL OF CHROMATOGRAPHY, 1985, 338 (01): : 99 - 112
  • [6] EDSTEIN MD, 1986, J CHROMATOGR, V380, P184, DOI 10.1016/S0378-4347(00)83641-5
  • [7] RELATION BETWEEN CHLOROGUANIDE BIOACTIVATION TO CYCLOGUANIL AND THE GENETICALLY-DETERMINED METABOLISM OF MEPHENYTOIN IN HUMANS
    FUNCKBRENTANO, C
    BOSCO, O
    JACQZAIGRAIN, E
    KEUNDJIAN, A
    JAILLON, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) : 507 - 512
  • [8] FunckBrentano C, 1997, J PHARMACOL EXP THER, V280, P730
  • [9] FUNCKBRENTANO C, 1992, J PHARMACOL EXP THER, V263, P780
  • [10] THE PHARMACOKINETICS AND ACTIVATION OF PROGUANIL IN MAN - CONSEQUENCES OF VARIABILITY IN DRUG-METABOLISM
    HELSBY, NA
    WARD, SA
    EDWARDS, G
    HOWELLS, RE
    BRECKENRIDGE, AM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) : 593 - 598